This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gorodeski, G. I. Articles by Utian, W. H. Search for Related Content PubMed PubMed Citation Articles by Gorodeski, G. I. Articles by Yang, T. Articles by Levy, M. N. Articles by Goldfarb, J. Articles by Utian, W. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ESTRADIOL NORETHINDRONE PROGESTERONE Social Bookmarking                   What's this?

Modulation of Coronary Vascular Resistance in Female Rabbits by Estrogen and Progesterone

Tianen Yang, PhD

Matthew N. Levy, MD

James Goldfarb, MD

Wulf H. Utian, MD, PhD

Departments of Reproductive Biology, and Physiology and Biophysics, Case Western Reserve University School of Medicine; Division of Investigative Medicine, Mt. Sinai Medical Center, Cleveland, Ohio

Objective: To study the roles of estradiol and various progestins on the regulation of coronary flow in female rabbits.

Methods: Ovariectomized adult female rabbits were treated with estradiol, with progesterone (or one of the following synthetic progestins: megace, norethindrone, or medroxyprogesterone acetate), or with both an estradiol and a progestin. Hearts were isolated and perfused at constant pressure by a modified Langendorff technique. Changes in coronary flow were determined at baseline and in response to direct infusion into the coronary circulation of N^G-nitro-L-arginine (L-NNA), an inhibitor of nitric oxide (NO) synthase.

Results: Coronary flow rates were 40-50% greater in hearts of animals treated with estradiol than in control hearts of animals not treated with the hormone. Treatment of the animals with progestin alone had little effect on coronary flow. However, when administered with estradiol, it abrogated the estradiol-related increase in coronary flow. The increments in coronary flow evoked by estradiol were virtually abolished by L-NNA, an inhibitor of NO synthase. In hearts of animals treated with estradiol plus progesterone, L-NNA had no additional inhibitory effect on coronary flow to that of progesterone.

Conclusion: Estradiol decreases coronary vascular resistance (CVR) and hence increases coronary flow. Progestins attenuate this effect of estradiol.

Key Words: Vasorelaxation • coronary vascular resistance • resistance arterioles

Journal of the Society for Gynecologic Investigation, Vol. 5, No. 4, 197-202 (1998)
DOI: 10.1177/107155769800500407


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?